SRAM
VIVO

Stone Ridge Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Stone Ridge Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-44,432
Closed -$1.03M – 541
2020
Q2 		$1.03M Hold
44,432
– – 0.17% 103
2020
Q1 		$373K Buy
44,432
+1,400
+3% +$11.8K 0.04% 458
2019
Q4 		$420K Hold
43,032
– – 0.03% 693
2019
Q3 		$408K Buy
43,032
+2,300
+6% +$24.2K 0.02% 763
2019
Q2 		$484K Buy
40,732
+8,275
+25% +$99.7K 0.03% 728
2019
Q1 		$572K Sell
32,457
-6,690
-17% -$111K 0.03% 669
2018
Q4 		$680K Buy
39,147
+1,412
+4% +$24.1K 0.04% 616
2018
Q3 		$562K Buy
37,735
+200
+0.5% +$3.1K 0.03% 790
2018
Q2 		$597K Sell
37,535
-855
-2% -$12.8K 0.03% 699
2018
Q1 		$545K Hold
38,390
– – 0.03% 735
2017
Q4 		$537K Buy
+38,390
New +$562K 0.03% 769

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Stone Ridge Asset Management's VIVO Position: Q3 2020 in Review

Stone Ridge Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2020, closing a stake of 44,432 shares — an estimated $1.03M sold.

Stone Ridge Asset Management first reported a position in VIVO in Q4 2017 and held it in 11 quarters. The position peaked at $1.03M in Q2 2020. 191 funds tracked by Wall St. Rank hold VIVO as of Q3 2020.

  • Stone Ridge Asset Management reported no remaining Meridian Bioscience Inc position as of Q3 2020 after selling out during the quarter.
  • Stone Ridge Asset Management sold 44,432 Meridian Bioscience Inc shares in Q3 2020, an estimated $1.03M.
  • Stone Ridge Asset Management first reported a position in Meridian Bioscience Inc in Q4 2017 and held it in 11 quarters.
  • Stone Ridge Asset Management's Meridian Bioscience Inc position peaked at $1.03M in Q2 2020.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2020.

Based on Stone Ridge Asset Management's 13F filing for Q3 2020.